All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

38

Reset

38 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AK117Phase 314 trials

    Akeso · Advanced Malignant Tumors, ACUTE MYELOID LEUKEMIA; AML, Higher-risk Myelodysplastic Syndromes

  • APG-2575lisaftoclaxPhase 310 trials

    Ascentage Pharma Group Inc. · CLL/SLL, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

  • OlverembatinibPhase 34 trials

    Ascentage Pharma Group Inc. · Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed/Refractory Acute Myeloid Leukaemia

  • BL-M11D1Phase 32 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Acute Myeloid Leukemia, Myelodysplastic Syndromes

  • BleximenibJNJ-75276617Phase 32 trials

    Johnson & Johnson (Janssen) · Acute Leukemia, Leukemia, Myeloid, Acute

  • ClifutinibHEC73543Phase 32 trials

    Sunshine Lake Pharma Co., Ltd. · Leukemia, Acute Myeloid (AML), Acute Myeloid Leukemia, Adult

  • CrenolanibPhase 32 trials

    Arog Pharmaceuticals, Inc. · Newly Diagnosed FLT3 Mutated AML, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

  • GM-CSFPhase 32 trials

    Y-mAbs Therapeutics · Neuroblastoma, Acute Myeloid Leukemia

  • HMPL-306Phase 32 trials

    Hutchmed · Acute Myeloid Leukemia, Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

  • ASTX030cedazuridine + azacitidinePhase 31 trial

    Taiho Oncology, Inc. · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm

  • XY0206Phase 31 trial

    Shijiazhuang Yiling Pharmaceutical Co. Ltd · Acute Myeloid Leukemia With FLT3/ITD Mutation

  • RimiducidAP1903Phase 23 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • RVU120SEL120Phase 23 trials

    Ryvu Therapeutics SA · Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome

  • bexmarilimabFP-1305Phase 22 trials

    Faron Pharmaceuticals Ltd · Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia

  • CusatuzumabOV-1001, JNJ-74494550Phase 22 trials

    OncoVerity, Inc. · Leukemia, Myeloid, Acute

  • IMGN632Phase 22 trials

    AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia

  • rivogenlecleucelBPX-501 T cells, BPX-501Phase 22 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • AB8939Phase 21 trial

    AB Science · Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia

  • ABD-3001DIMATEPhase 21 trial

    Advanced BioDesign · Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes

  • AG-120Phase 21 trial

    Bristol Myers Squibb · Leukemia, Myeloid, Acute

  • AG-221Phase 21 trial

    Bristol Myers Squibb · Leukemia, Myeloid, Acute

  • ARD103Phase 21 trial

    ARCE Therapeutics, Inc. · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, MDS (Myelodysplastic Syndrome)

  • BG1805Phase 21 trial

    Guangzhou Bio-gene Technology Co., Ltd · Leukemia, Myeloid, Acute

  • BP1001Phase 21 trial

    Bio-Path Holdings, Inc. · Acute Myeloid Leukemia (AML)

  • CFI-400945Phase 21 trial

    Treadwell Therapeutics, Inc · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia

  • CLN-049Phase 21 trial

    Cullinan Therapeutics Inc. · Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), TP53-mutated MDS and AML

  • CTX-712Phase 21 trial

    Chordia Therapeutics, Inc. · Acute Myeloid Leukemia, Myelodysplastic Syndromes

  • Debio 1562MPhase 21 trial

    Debiopharm International SA · Acute Myeloid Leukemia

  • EP0042Phase 21 trial

    Ellipses Pharma · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes

  • MAX-40279Phase 21 trial

    Maxinovel Pty., Ltd. · Acute Myeloid Leukemia

  • PBSS1113Phase 21 trial

    Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)

  • S241656Phase 21 trial

    Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia

  • S243249Phase 21 trial

    Servier · Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Myeloid Leukemia

  • SKLB1028Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Newly Diagnosed Acute Myeloid Leukemia (AML)

  • TBS-2025trovostobartPhase 21 trial

    TuHURA Biosciences, Inc. · Acute Myeloid Leukemia

  • TGRX-814Phase 21 trial

    Shenzhen TargetRx Co., Ltd. · Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia

  • TuspetinibHM43239Phase 21 trial

    Aptose Biosciences Inc. · Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML

  • VTRU200Phase 21 trial

    Vitruviae · Acute Myeloid Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), High Risk Myelodysplastic Syndrome

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.